BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25632961)

  • 1. Reciprocal regulation of AMP-activated protein kinase and phospholipase D.
    Mukhopadhyay S; Saqcena M; Chatterjee A; Garcia A; Frias MA; Foster DA
    J Biol Chem; 2015 Mar; 290(11):6986-93. PubMed ID: 25632961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes.
    Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH
    Alcohol Clin Exp Res; 2013 Nov; 37(11):1849-61. PubMed ID: 23895284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).
    Foster DA; Salloum D; Menon D; Frias MA
    J Biol Chem; 2014 Aug; 289(33):22583-22588. PubMed ID: 24990952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).
    Xu L; Salloum D; Medlin PS; Saqcena M; Yellen P; Perrella B; Foster DA
    J Biol Chem; 2011 Jul; 286(29):25477-86. PubMed ID: 21622984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase D1 is an effector of Rheb in the mTOR pathway.
    Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle.
    Hornberger TA; Chu WK; Mak YW; Hsiung JW; Huang SA; Chien S
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4741-6. PubMed ID: 16537399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
    Liu Y; Käch A; Ziegler U; Ong AC; Wallace DP; Arcaro A; Serra AL
    PLoS One; 2013; 8(8):e73173. PubMed ID: 24009738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
    Foster DA
    Biochim Biophys Acta; 2009 Sep; 1791(9):949-55. PubMed ID: 19264150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling.
    Jaafar R; De Larichaudy J; Chanon S; Euthine V; Durand C; Naro F; Bertolino P; Vidal H; Lefai E; Némoz G
    Cell Commun Signal; 2013 Aug; 11():55. PubMed ID: 23915343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR.
    Lehman N; Ledford B; Di Fulvio M; Frondorf K; McPhail LC; Gomez-Cambronero J
    FASEB J; 2007 Apr; 21(4):1075-87. PubMed ID: 17242159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidic acid and lipid-sensing by mTOR.
    Foster DA
    Trends Endocrinol Metab; 2013 Jun; 24(6):272-8. PubMed ID: 23507202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid sensing by mTOR complexes via
    Menon D; Salloum D; Bernfeld E; Gorodetsky E; Akselrod A; Frias MA; Sudderth J; Chen PH; DeBerardinis R; Foster DA
    J Biol Chem; 2017 Apr; 292(15):6303-6311. PubMed ID: 28223357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR signaling: PLD takes center stage.
    Sun Y; Chen J
    Cell Cycle; 2008 Oct; 7(20):3118-23. PubMed ID: 18927511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.
    El Osta M; Liu M; Adada M; Senkal CE; Idkowiak-Baldys J; Obeid LM; Clarke CJ; Hannun YA
    FASEB J; 2014 Jan; 28(1):495-505. PubMed ID: 24121461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mTOR by phosphatidic acid?
    Foster DA
    Cancer Res; 2007 Jan; 67(1):1-4. PubMed ID: 17210675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.
    Lyo D; Xu L; Foster DA
    Biochem Biophys Res Commun; 2010 May; 396(2):562-5. PubMed ID: 20438709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.
    Frias MA; Mukhopadhyay S; Lehman E; Walasek A; Utter M; Menon D; Foster DA
    J Biol Chem; 2020 Jan; 295(1):263-274. PubMed ID: 31767684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.